Aurora Cannabis hostile bid for CanniMed Therapeutics

Overview:

• Aurora Cannabis has made a hostile bid for CanniMed Therapeutics.
• The bid was made as CanniMed was bidding for Newstrike Resources.
• The deal value will aggregate to C$1.2 billion.
• Canaccord Genuity has acted as financial advisor to Aurora, while AltaCorp Capital has provided financial advice to CanniMed.
• Kingsdale Advisors was a strategic shareholder and communications advisor to CanniMed.
• Cormark Securities provided financial advice to the special committee of CanniMed.

Katrin Kostadinova - Data analyst